Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Balsa

Showing results (181-190 of 246) with videos related to

Pageof 25
Sort By:
Annals of the Rheumatic Diseases|July 2, 2020
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseasesLaura Nuño, Marta Novella Navarro, Gema Bonilla, et al.
Atherosclerosis|September 6, 2011
Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritisRaquel López-Mejías, Mercedes García-Bermúdez, Carlos González-Juanatey, et al.
Annals of the Rheumatic Diseases|September 30, 2010
Analysis of the REL polymorphism rs13031237 in autoimmune diseasesJezabel Varadé, Rogelio Palomino-Morales, Norberto Ortego-Centeno, et al.
Rheumatology International|December 29, 2014
Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritisEstíbaliz Loza, Cristina Lajas, Jose Luis Andreu, et al.
Nutrients|March 13, 2025
Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?Marta Novella-Navarro, Ana Van Den Rym, Chary López-Pedrera, et al.
Frontiers in Immunology|September 25, 2020
Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid ArthritisEulalia Rodríguez-Martín, Israel Nieto-Gañán, Borja Hernández-Breijo, et al.
Heliyon|December 22, 2017
REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patientsIsidoro González-Álvaro, Antonio J Blasco, Pablo Lázaro, et al.
Reumatologia Clinica|September 28, 2024
Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritisJosé María Álvaro-Gracia Álvaro, Petra Díaz Del Campo Fontecha, José Luis Andréu Sánchez, et al.
Reumatologia Clinica|June 9, 2015
2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritisRaimon Sanmartí, Susana García-Rodríguez, José María Álvaro-Gracia, et al.
Clinical and Experimental Rheumatology|May 24, 2016
Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activityChamaida Plasencia, Gertjan Wolbink, Charlotte L M Krieckaert, et al.
Pageof 25

Showing results (181-190 of 246) with videos related to

Sort By:
Pageof 25
Annals of the Rheumatic Diseases|July 2, 2020
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseasesLaura Nuño, Marta Novella Navarro, Gema Bonilla, et al.
Atherosclerosis|September 6, 2011
Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritisRaquel López-Mejías, Mercedes García-Bermúdez, Carlos González-Juanatey, et al.
Annals of the Rheumatic Diseases|September 30, 2010
Analysis of the REL polymorphism rs13031237 in autoimmune diseasesJezabel Varadé, Rogelio Palomino-Morales, Norberto Ortego-Centeno, et al.
Rheumatology International|December 29, 2014
Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritisEstíbaliz Loza, Cristina Lajas, Jose Luis Andreu, et al.
Nutrients|March 13, 2025
Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?Marta Novella-Navarro, Ana Van Den Rym, Chary López-Pedrera, et al.
Frontiers in Immunology|September 25, 2020
Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid ArthritisEulalia Rodríguez-Martín, Israel Nieto-Gañán, Borja Hernández-Breijo, et al.
Heliyon|December 22, 2017
REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patientsIsidoro González-Álvaro, Antonio J Blasco, Pablo Lázaro, et al.
Reumatologia Clinica|September 28, 2024
Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritisJosé María Álvaro-Gracia Álvaro, Petra Díaz Del Campo Fontecha, José Luis Andréu Sánchez, et al.
Reumatologia Clinica|June 9, 2015
2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritisRaimon Sanmartí, Susana García-Rodríguez, José María Álvaro-Gracia, et al.
Clinical and Experimental Rheumatology|May 24, 2016
Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activityChamaida Plasencia, Gertjan Wolbink, Charlotte L M Krieckaert, et al.
Pageof 25